MX2024005884A - Usos de compuestos biciclicos para el tratamiento de enfermedades. - Google Patents

Usos de compuestos biciclicos para el tratamiento de enfermedades.

Info

Publication number
MX2024005884A
MX2024005884A MX2024005884A MX2024005884A MX2024005884A MX 2024005884 A MX2024005884 A MX 2024005884A MX 2024005884 A MX2024005884 A MX 2024005884A MX 2024005884 A MX2024005884 A MX 2024005884A MX 2024005884 A MX2024005884 A MX 2024005884A
Authority
MX
Mexico
Prior art keywords
diseases
treatment
bicyclic compounds
compounds
compositions
Prior art date
Application number
MX2024005884A
Other languages
English (en)
Spanish (es)
Inventor
Robert Taylor
Douglas Boatman
Leen Kawas
Kevin Church
Jewel Johnston
Original Assignee
Athira Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athira Pharma Inc filed Critical Athira Pharma Inc
Publication of MX2024005884A publication Critical patent/MX2024005884A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2024005884A 2021-12-17 2022-12-16 Usos de compuestos biciclicos para el tratamiento de enfermedades. MX2024005884A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290783P 2021-12-17 2021-12-17
US202263312696P 2022-02-22 2022-02-22
PCT/US2022/053113 WO2023114456A1 (en) 2021-12-17 2022-12-16 Uses of bicyclic compounds for the treatment of diseases

Publications (1)

Publication Number Publication Date
MX2024005884A true MX2024005884A (es) 2024-05-29

Family

ID=86773494

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024005884A MX2024005884A (es) 2021-12-17 2022-12-16 Usos de compuestos biciclicos para el tratamiento de enfermedades.

Country Status (11)

Country Link
US (1) US20250041307A1 (https=)
EP (1) EP4448100A4 (https=)
JP (1) JP2024546600A (https=)
KR (1) KR20240121239A (https=)
AU (1) AU2022410646A1 (https=)
CA (1) CA3240896A1 (https=)
CL (1) CL2024001748A1 (https=)
IL (1) IL313039A (https=)
MX (1) MX2024005884A (https=)
TW (1) TW202339756A (https=)
WO (1) WO2023114456A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025515045A (ja) * 2022-05-04 2025-05-13 アティラ・ファーマ・インコーポレイテッド 神経炎症病態を治療する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184223B1 (en) * 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
AU2003284120A1 (en) * 2002-10-17 2004-05-04 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
EP2155226A4 (en) * 2007-06-14 2010-07-28 Univ California COMPOUNDS FOR INHIBITING THE PROTEIN AGGREGATION AND METHOD FOR THE PRODUCTION AND USE THEREOF
KR20130139895A (ko) * 2010-09-02 2013-12-23 다케다 야쿠힌 고교 가부시키가이샤 경도인지 장애의 치료 또는 예방용 융합 트리아졸
CA2817975C (en) * 2010-11-16 2020-03-31 Michael Kahn Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
AP2014007606A0 (en) * 2011-10-07 2014-05-31 Takeda Pharmaceutical 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
CN119684295A (zh) * 2020-11-02 2025-03-25 雅斯娜制药公司 用于治疗疾病的双环化合物及其用途

Also Published As

Publication number Publication date
CL2024001748A1 (es) 2024-11-22
WO2023114456A1 (en) 2023-06-22
TW202339756A (zh) 2023-10-16
CA3240896A1 (en) 2023-06-22
KR20240121239A (ko) 2024-08-08
EP4448100A4 (en) 2025-10-22
US20250041307A1 (en) 2025-02-06
IL313039A (en) 2024-07-01
AU2022410646A1 (en) 2024-05-30
JP2024546600A (ja) 2024-12-26
EP4448100A1 (en) 2024-10-23

Similar Documents

Publication Publication Date Title
MX2023004942A (es) Compuestos biciclicos y usos de los mismos para el tratamiento de enfermedades.
MX2024006123A (es) Triptaminas especificas para usarse en el tratamiento de trastornos de estado de animo.
MX2022010425A (es) Metodos de tratamiento de enfermedades asociadas a los receptores de estrogenos.
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
EP4620469A3 (en) Tricyclic urea compounds as jak2 v617f inhibitors
MX2020008680A (es) Terapia de combinacion con apilimod y agentes glutamatergicos.
EP4438114A3 (en) Methods of making bempedoic acid and compositions of the same
PH12022553019A1 (en) Il-17a modulators
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
MY140767A (en) Compounds, methods and compositions
MX2021011488A (es) Compuestos y usos de estos.
MX2025002953A (es) Derivados heteroaromaticos y aromaticos heterobiciclicos para el tratamiento de trastornos relacionados con ferroptosis
PH12022500021A1 (en) Il-17a modulators
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
MY140169A (en) Compounds, compositions, and methods
MX2025005941A (es) Moduladores de la actividad tnf-\03b1
MX2021007948A (es) Inhibidores de proteina de activacion de fibroblastos.
MX2022000712A (es) Moduladores de nlrp3.
MX2024011254A (es) Moduladores de nlrp3
WO2022175746A8 (en) Tyk2 inhibitors and uses thereof
MX2023008589A (es) Compuestos moduladores de gcn2 y usos de los mismos.
MX2025007184A (es) Triterpenoides sinteticos heteroaromaticos sustituidos polarmente en c17, y metodos de uso de los mismos
PH12022552447A1 (en) Nlrp3 modulators
WO2020154571A8 (en) Compounds and uses thereof
MY209530A (en) Methods and compositions for the treatment of hair loss